Seppo Ylä‐Herttuala

61.9k total citations · 7 hit papers
748 papers, 44.5k citations indexed

About

Seppo Ylä‐Herttuala is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Seppo Ylä‐Herttuala has authored 748 papers receiving a total of 44.5k indexed citations (citations by other indexed papers that have themselves been cited), including 444 papers in Molecular Biology, 175 papers in Genetics and 159 papers in Surgery. Recurrent topics in Seppo Ylä‐Herttuala's work include Virus-based gene therapy research (162 papers), Angiogenesis and VEGF in Cancer (154 papers) and Atherosclerosis and Cardiovascular Diseases (93 papers). Seppo Ylä‐Herttuala is often cited by papers focused on Virus-based gene therapy research (162 papers), Angiogenesis and VEGF in Cancer (154 papers) and Atherosclerosis and Cardiovascular Diseases (93 papers). Seppo Ylä‐Herttuala collaborates with scholars based in Finland, United States and United Kingdom. Seppo Ylä‐Herttuala's co-authors include Kari Alitalo, Wulf Palinski, Joseph L. Witztum, Michael E. Rosenfeld, Daniel Steinberg, Tuomas T. Rissanen, Jukka Luoma, T E Carew, Sampath Parthasarathy and Mikko P. Turunen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Seppo Ylä‐Herttuala

736 papers receiving 43.4k citations

Hit Papers

Evidence for the presence... 1989 2026 2001 2013 1989 1989 1992 1991 2001 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Seppo Ylä‐Herttuala 21.8k 9.9k 9.0k 8.3k 5.3k 748 44.5k
Michael B. Sporn 44.7k 2.0× 12.8k 1.3× 5.3k 0.6× 8.4k 1.0× 8.0k 1.5× 512 73.5k
Tatsuhiko Kodama 20.1k 0.9× 6.7k 0.7× 4.8k 0.5× 9.3k 1.1× 2.5k 0.5× 426 36.3k
Michael A. Gimbrone 16.2k 0.7× 3.6k 0.4× 6.4k 0.7× 12.9k 1.6× 1.7k 0.3× 185 42.7k
Göran K. Hansson 14.0k 0.6× 4.6k 0.5× 9.5k 1.0× 28.1k 3.4× 1.8k 0.3× 455 53.2k
Kenneth Walsh 28.3k 1.3× 4.3k 0.4× 7.2k 0.8× 6.2k 0.7× 2.9k 0.5× 462 54.0k
Ryozo Nagai 18.1k 0.8× 2.9k 0.3× 7.4k 0.8× 4.7k 0.6× 4.8k 0.9× 859 45.6k
Andreas M. Zeiher 32.0k 1.5× 5.6k 0.6× 17.6k 2.0× 8.2k 1.0× 1.5k 0.3× 564 69.3k
Stefanie Dimmeler 42.9k 2.0× 6.7k 0.7× 15.9k 1.8× 9.3k 1.1× 1.8k 0.3× 518 73.2k
Guy A. Zimmerman 10.5k 0.5× 2.5k 0.3× 3.9k 0.4× 8.6k 1.0× 2.1k 0.4× 262 32.6k
Ira Tabas 20.0k 0.9× 2.6k 0.3× 10.9k 1.2× 15.8k 1.9× 1.3k 0.2× 278 46.3k

Countries citing papers authored by Seppo Ylä‐Herttuala

Since Specialization
Citations

This map shows the geographic impact of Seppo Ylä‐Herttuala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppo Ylä‐Herttuala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppo Ylä‐Herttuala more than expected).

Fields of papers citing papers by Seppo Ylä‐Herttuala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seppo Ylä‐Herttuala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppo Ylä‐Herttuala. The network helps show where Seppo Ylä‐Herttuala may publish in the future.

Co-authorship network of co-authors of Seppo Ylä‐Herttuala

This figure shows the co-authorship network connecting the top 25 collaborators of Seppo Ylä‐Herttuala. A scholar is included among the top collaborators of Seppo Ylä‐Herttuala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seppo Ylä‐Herttuala. Seppo Ylä‐Herttuala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martini, Alberto, Ganiraju C. Manyam, Yan Chen, et al.. (2024). Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model. Frontiers in Immunology. 15. 1387229–1387229. 2 indexed citations
2.
Jahromi, Behnam Rezai, Miko Valori, Riikka Tulamo, et al.. (2024). Cancer-type somatic mutations in saccular cerebral aneurysms. European Journal of Human Genetics. 33(8). 1076–1079.
3.
Hosseini, Seyed Younes, Rahul Mallick, Petri Mäkinen, & Seppo Ylä‐Herttuala. (2024). Navigating the prime editing strategy to treat cardiovascular genetic disorders in transforming heart health. Expert Review of Cardiovascular Therapy. 22(1-3). 75–89. 1 indexed citations
4.
Ruotsalainen, Anna‐Kaisa, et al.. (2024). The mechanisms of Chr.9p21.3 risk locus in coronary artery disease: where are we today?. American Journal of Physiology-Heart and Circulatory Physiology. 328(2). H196–H208. 1 indexed citations
5.
Kaljunen, Heidi, Lucia Nappi, Ladan Fazli, et al.. (2024). DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications Biology. 7(1). 108–108. 8 indexed citations
6.
Ruotsalainen, Anna‐Kaisa, Tiit Örd, Janne Heikkilä, et al.. (2023). Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity. Frontiers in Cardiovascular Medicine. 10. 1113890–1113890. 5 indexed citations
7.
Abdollahzadeh, Ali, H. Y. Huang, Fabrizio Orsenigo, et al.. (2023). SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space. Scientific Reports. 13(1). 7279–7279. 5 indexed citations
8.
Kivelä, Antti, et al.. (2022). Intramyocardial adenoviral vascular endothelial growth factor‐D∆N∆C gene therapy does not induce ventricular arrhythmias. The Journal of Gene Medicine. 24(8). e3437–e3437. 3 indexed citations
9.
Mäkinen, Petri I., Minna U. Kaikkonen, Marc S. Weinberg, et al.. (2022). Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia. PLoS ONE. 17(3). e0265948–e0265948. 12 indexed citations
10.
Ståhle, Mia, Sanna Hellberg, Jenni Virta, et al.. (2021). Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer Ga-68-NODAGA-exendin-4. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
11.
Korpela, H, Rahul Mallick, Pyry I. Toivanen, et al.. (2021). Adenoviral VEGF-B186R127S gene transfer induces angiogenesis and improves perfusion in ischemic heart. iScience. 24(12). 103533–103533. 6 indexed citations
12.
Afara, Isaac O., Mikko J. Nissi, Paavo Halonen, et al.. (2020). Quantification of Myocardial Blood Flow by Machine Learning Analysis of Modified Dual Bolus MRI Examination. Annals of Biomedical Engineering. 49(2). 653–662. 4 indexed citations
13.
Choi, Woonyoung, Sharada Mokkapati, Debasish Sundi, et al.. (2019). Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. OncoImmunology. 8(5). e1577125–e1577125. 10 indexed citations
14.
Sallinen, Hanna, J. Koponen, Maarit Anttila, et al.. (2013). Preclinical Safety, Toxicology, and Biodistribution Study of Adenoviral Gene Therapy with sVEGFR-2 and sVEGFR-3 Combined with Chemotherapy for Ovarian Cancer. PubMed. 24(1). 29–37. 9 indexed citations
15.
Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations
16.
Samaranayake, Haritha, et al.. (2009). Challenges in monoclonal antibody-based therapies. Annals of Medicine. 41(5). 322–331. 137 indexed citations
17.
Rossi, Derrick J., Iiro Rajantie, Seppo Ylä‐Herttuala, et al.. (2008). Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proceedings of the National Academy of Sciences. 105(18). 6620–6625. 294 indexed citations
18.
Bałuk, Peter, Tuomas Tammela, Natalya Lyubynska, et al.. (2005). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. Journal of Clinical Investigation. 115(2). 247–257. 470 indexed citations
19.
Krebs, R., Jussi Tikkanen, Antti I. Nykänen, et al.. (2005). Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 171(12). 1421–1429. 37 indexed citations
20.
Pakkanen, Timo, Jukka Luoma, Saila Laakso, et al.. (1996). Local adventitial VEGF gene transfer reduces neointima formation in rabbit carotid arteries. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026